Institutional investors purchased a net $1.5 million shares of IMMU during the quarter ended March 2016, and now own 51.84% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ACUTA CAPITAL PARTNERS LLC Bought 1.6 Million shares of Immunomedics Inc
PERCEPTIVE ADVISORS LLC Bought 1.2 Million shares of Immunomedics Inc
VENBIO SELECT ADVISOR LLC Bought 1.1 Million shares of Immunomedics Inc